Cargando…
Heat Shock Proteins and PD-1/PD-L1 as Potential Therapeutic Targets in Myeloproliferative Neoplasms
SIMPLE SUMMARY: Myeloproliferative neoplasms (MPN), which are a heterogeneous group of rare disorders that affect blood cell production in bone marrow, present many significant challenges for clinicians. Though considerable progress has been made, in particular with the JAK1/2 inhibitor ruxolitinib,...
Autores principales: | De Almeida, Steven, Regimbeau, Mathilde, Jego, Gaëtan, Garrido, Carmen, Girodon, François, Hermetet, François |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563255/ https://www.ncbi.nlm.nih.gov/pubmed/32932806 http://dx.doi.org/10.3390/cancers12092592 |
Ejemplares similares
-
Chaperoning STAT3/5 by Heat Shock Proteins: Interest of Their Targeting in Cancer Therapy
por: Jego, Gaëtan, et al.
Publicado: (2019) -
Heat-Shock Proteins in Leukemia and Lymphoma: Multitargets for Innovative Therapeutic Approaches
por: Cabaud-Gibouin, Vincent, et al.
Publicado: (2023) -
Genetic Background of Polycythemia Vera
por: Regimbeau, Mathilde, et al.
Publicado: (2022) -
HSP90 and HSP70: Implication in Inflammation Processes and Therapeutic Approaches for Myeloproliferative Neoplasms
por: Sevin, Margaux, et al.
Publicado: (2015) -
PD-1 inhibition in advanced myeloproliferative neoplasms
por: Hobbs, Gabriela, et al.
Publicado: (2021)